Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-06

FDA Approved: DIMETHYL FUMARATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's generic dimethyl fumarate in an original application for the treatment of relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dimethyl fumarate (Dimethyl fumarate)

Snippet

ORIG AP for DIMETHYL FUMARATE (DIMETHYL-FUMARATE)